Core Insights - The article highlights the dissatisfaction of parents regarding the quality and pricing of the "Ultraman" children's theater performances, which are significantly more expensive than movie tickets, leading to complaints about misleading advertising and poor execution [1][2][3] Group 1: Performance Quality and Consumer Experience - Parents reported that the performances, priced at six times that of movie tickets, failed to deliver promised experiences, such as VIP packages and quality production values, resulting in disappointment for both children and parents [2][3] - The performances were criticized for lacking professional production elements, with costumes that did not adequately conceal performers and overall poor audio-visual quality [2][3] - Legal experts indicated that consumers could claim refunds based on misleading advertising and unmet contractual obligations, emphasizing the need for higher quality standards in children's cultural products [3] Group 2: Licensing and Authorization Issues - The article discusses the confusion surrounding the licensing of "Ultraman" performances, noting that multiple companies hold different rights to the IP, leading to inconsistencies in quality and pricing [6][7] - The authorization fees for performances can be as low as 3,000 yuan per show, raising concerns about the quality of productions that can be offered at such low costs [5][6] - The original rights holder, New Chuanghua, has not authorized cinema performances, indicating potential unauthorized use of the IP by other companies [5][6] Group 3: Market Dynamics and Financial Implications - The article outlines the significant financial potential of the "Ultraman" IP, with estimates suggesting that the licensing and derivative product market could be worth tens of billions, highlighting the long-term financial impact of historical licensing decisions [7][9] - Companies leveraging the "Ultraman" IP have seen substantial revenue growth, with examples of firms achieving over 100 billion yuan in revenue due to successful product lines based on the IP [9][10] - The fragmented licensing landscape has led to market confusion and varying product quality, which could harm the brand's reputation and consumer trust [8][10]

Core Viewpoint - The article discusses the issues surrounding the performance of the Ultraman children's theater, highlighting consumer dissatisfaction due to high ticket prices and poor quality of the shows, which raises concerns about misleading advertising and the authenticity of licensing agreements [2][5][7]. Group 1: Consumer Experience - Parents are willing to pay high prices for children's shows, but many report disappointment due to false advertising and poor performance quality [2][5]. - Specific complaints include missing promised perks, such as VIP packages, and subpar production values, leading to a negative experience for children [5][6]. - Legal experts suggest that consumers may have grounds for claims under consumer protection laws due to misleading advertising practices [7][16]. Group 2: Licensing and Authorization Issues - The Ultraman IP is highly lucrative, generating $7.4 billion in total revenue in 2024, ranking it as the 53rd most profitable IP globally [3]. - There are discrepancies in licensing fees, with some performances authorized for as low as 3,000 yuan, raising questions about the legitimacy of these licenses [3][15]. - The core copyright holder, New Chuanghua, has stated that they have not authorized theater performances in cinemas, indicating potential unauthorized use of the IP [15][17]. Group 3: Market Dynamics and Historical Context - The article outlines a complex licensing landscape where multiple companies hold different rights to the Ultraman IP, leading to inconsistent quality and consumer confusion [18][19]. - Historical contracts from 1976 have resulted in fragmented rights, complicating the current market and potentially leading to significant financial losses for the original copyright holder [19][24]. - The article emphasizes the importance of proper IP management and the need for companies to establish robust licensing frameworks to avoid future disputes and protect brand integrity [26].